TD Private Client Wealth’s Alnylam Pharmaceuticals ALNY Stock Holding History

TD Private Client Wealth’s Portfolio ALNY Stock Details ALNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$491K	Buy	1,990 +1,929	+3,162%	+$491K	0.01%	481
2026 Q2	$18.4K	Buy	61 +2	+3%	+$603	﹤0.01%	1047
2026 Q1	$19.5K	Buy	59 +56	+1,867%	+$19.1K	﹤0.01%	1014
2025 Q4	$1.19K	Hold	3	–	–	﹤0.01%	1343
2025 Q3	$1.37K	Buy	3 +2	+200%	+$814	﹤0.01%	1290
2025 Q2	$326	Hold	1	–	–	﹤0.01%	1360
2025 Q1	$270	Buy	+1	New	+$257	﹤0.01%	1367
2023 Q3	–	Sell	-9	Closed	-$1.71K	–	1215
2023 Q2	$1.71K	Hold	9	–	–	﹤0.01%	1178
2023 Q1	$1.8K	Hold	9	–	–	﹤0.01%	1161
2022 Q4	$2.14K	Hold	9	–	–	﹤0.01%	1114
2022 Q3	$1.8K	Hold	9	–	–	﹤0.01%	1117
2022 Q2	$1.31K	Hold	9	–	–	﹤0.01%	1160
2022 Q1	$1.47K	Sell	9 -6	-40%	-$914	﹤0.01%	1188
2021 Q4	$2.54K	Sell	15 -18	-55%	-$3.34K	﹤0.01%	996
2021 Q3	$6.23K	Hold	33	–	–	﹤0.01%	944
2021 Q2	$5.59K	Hold	33	–	–	﹤0.01%	949
2021 Q1	$4.66K	Hold	33	–	–	﹤0.01%	934
2020 Q4	$4.29K	Sell	33 -45	-58%	-$6.01K	﹤0.01%	903
2020 Q3	$11.4K	Hold	78	–	–	﹤0.01%	780
2020 Q2	$11.6K	Hold	78	–	–	﹤0.01%	785
2020 Q1	$8.49K	Buy	78 +3	+4%	+$346	﹤0.01%	771
2019 Q4	$8.64K	Buy	+75	New	+$7.48K	﹤0.01%	768

Other funds holding ALNY

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

IFM Investors Melbourne, Australia $16B AUM 33.69% 1-Year Est. Return

GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return

China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return

TD Private Client Wealth's ALNY Position: Q3 2026 in Review

TD Private Client Wealth increased its Alnylam Pharmaceuticals (ALNY) stake by 3,162% in Q3 2026, buying an estimated $491K and bringing the position to 1,990 shares worth $491K. The position accounts for 0.01% of the portfolio, ranked #481.

TD Private Client Wealth first reported a position in ALNY in Q4 2019 and has held it in 22 quarters since. 174 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.

TD Private Client Wealth held 1,990 shares of Alnylam Pharmaceuticals worth $491K as of Q3 2026.
TD Private Client Wealth bought 1,929 Alnylam Pharmaceuticals shares in Q3 2026, an estimated $491K.
Alnylam Pharmaceuticals made up 0.01% of TD Private Client Wealth's portfolio in Q3 2026, its #481 holding.
TD Private Client Wealth first reported a position in Alnylam Pharmaceuticals in Q4 2019 and has held it in 22 quarters since.
174 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.

Based on TD Private Client Wealth's 13F filing for Q3 2026, filed 28 Oct 2026.